Heart Test Laboratories (NASDAQ:HSCS) Stock Rating Reaffirmed by Ascendiant Capital Markets

Heart Test Laboratories (NASDAQ:HSCS)‘s stock had its “buy” rating reiterated by investment analysts at Ascendiant Capital Markets in a research note issued on Monday, Benzinga reports. They presently have a $15.00 price objective on the stock. Ascendiant Capital Markets’ price target would suggest a potential upside of 252.94% from the stock’s previous close.

Heart Test Laboratories Stock Up 44.6 %

Shares of HSCS stock opened at $4.25 on Monday. The business has a 50-day moving average price of $3.39 and a two-hundred day moving average price of $6.44. Heart Test Laboratories has a 12-month low of $2.36 and a 12-month high of $52.00. The firm has a market cap of $2.79 million, a P/E ratio of -0.09 and a beta of 3.13.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.